Need help finding what you are looking for?
Contact Us
PUBLISHER: Grand View Research | PRODUCT CODE: 1571574
PUBLISHER: Grand View Research | PRODUCT CODE: 1571574
Peptide Synthesis Market Size, Share & Trends Analysis Report By Product (Equipment, Reagents & Consumables), By Application (Therapeutics, Diagnosis), By Technology, By End Use, By Region, And Segment Forecasts, 2024 - 2030
PUBLISHED:
PAGES: 100 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Peptide Synthesis Market Growth & Trends:
The global peptide synthesis market size is expected to reach USD 1.4 billion by 2030 growing at a CAGR of 12.7% from 2024 to 2030, according to a new report by Grand View Research, Inc. Significant research and innovation targeted towards the development of peptide therapeutics is set to boost the market growth in the near future. Additionally, increasing advancements in the peptide synthesis technologies is expected to offer profitable opportunities for the companies operating in the market.
A surge in the demand for custom peptide synthesis has been observed in the recent years; several companies operating in this industry offer products and services associated with custom peptide synthesis. For instance, a UK based company namely, Almac Group offers peptide synthesis suitable for research use. Constantly growing demand and evolving market landscape for custom peptides is set to offer lucrative opportunities for the market growth. The suppliers are expanding their production capacity to suffice the increasing demand for high quality peptides across research and therapeutics areas.
Rising focus of the pharmaceutical companies towards the development of novel biologics and shifting the peptide drugs from the pipeline stage to commercial scale further strengthens the market growth. Increase in the number of research activities performed on exploring the potential of high-quality peptides and peptide libraries in the development of vaccines and biomarker discovery heavily contributes to the revenue generated by the global peptide synthesis market. Moreover, introduction of modified peptides (GMP peptides) that possess enhanced stability and pharmacokinetic properties in the market is expected to maintain the double-digit market growth throughout the forecast period.
Therapeutic peptide development has witnessed remarkable growth in the recent years, this is further driven by significant increase in the patient pool suffering from cardiovascular and metabolic diseases. This has propelled the discovery of bioactive peptides exponentially which further drives the market demand.
Peptide Synthesis Market Report Highlights:
- Reagents & consumables accounted for the highest revenue generated in 2023 and is anticipated to maintain this trend throughout the forecast period.
- Peptide synthesis equipment has registered fastest growth during the forecast period
- Peptide synthesizers segment serves to be a major contributor to the revenue generated by equipment in the global market and is anticipated to grow at highest CAGR of 13.6% from 2024 to 2030 among other peptide synthesis equipment.
- Liquid phase peptide synthesis (LPPS) technology dominated the peptide synthesis market in 2023 and is expected to continue this dominance throughout the forecast period.
- Therapeutic peptide synthesis has garnered the largest share in the market in 2023 and is anticipated to maintain this trend throughout the forecast period.
- North America region has generated highest revenue in 2023 and is expected to maintain this dominance throughout the forecast period; sufficient presence of skilled professionals along with the strong network of peptide synthesis manufacturers is attributive to this region's dominance in the global market.
- APAC is expected to offer lucrative opportunities for the market expansion, attributed to rising focus on the development of peptide therapeutics.
- Large patient pool for cardiovascular and metabolic diseases in the APAC region has significantly contributed to the revenue generated, contributing to the highest CAGR registered during the forecast period.
Product Code: GVR-3-68038-697-4
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Market Definitions
- 1.3. Research Methodology
- 1.3.1. Information Procurement
- 1.3.2. Information or Data Analysis
- 1.3.3. Market Formulation & Data Visualization
- 1.3.4. Data Validation & Publishing
- 1.4. Research Scope and Assumptions
- 1.4.1. List of Data Sources
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
Chapter 3. Peptide Synthesis Market Variables, Trends, & Scope
- 3.1. Market Introduction/Lineage Outlook
- 3.2. Market Size and Growth Prospects (USD Million)
- 3.3. Market Dynamics
- 3.3.1. Market Drivers Analysis
- 3.3.2. Market Restraints Analysis
- 3.4. Peptide Synthesis Market Analysis Tools
- 3.4.1. Porter's Analysis
- 3.4.1.1. Bargaining power of the suppliers
- 3.4.1.2. Bargaining power of the buyers
- 3.4.1.3. Threats of substitution
- 3.4.1.4. Threats from new entrants
- 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
- 3.4.2.1. Political landscape
- 3.4.2.2. Economic and Social landscape
- 3.4.2.3. Technological landscape
- 3.4.2.4. Environmental landscape
- 3.4.2.5. Legal landscape
- 3.4.1. Porter's Analysis
Chapter 4. Peptide Synthesis Market: product Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Peptide Synthesis Market Product Movement Analysis, 2023 & 2030 (USD Million)
- 4.3. Equipment
- 4.3.1. Equipment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.3.2. Peptide Synthesizers
- 4.3.2.1. Peptide Synthesizers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.3.3. Lyophilizers
- 4.3.3.1. Lyophilizers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.3.4. Chromatography Equipment
- 4.3.4.1. Chromatography Equipment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.3.5. Others
- 4.3.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4. Reagents & Consumables
- 4.4.1. Reagents & Consumables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.2. Resins
- 4.4.2.1. Resins Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.3. Amino Acids
- 4.4.3.1. Amino Acids Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.4. Coupling Reagents
- 4.4.4.1. Coupling Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.5. Dyes & Fluroscent Labeling Reagents
- 4.4.5.1. Dyes & Fluroscent Labeling reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.6. Others
- 4.4.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5. Services
- 4.5.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Peptide Synthesis Market: Technology Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Peptide Synthesis Market: Technology Movement Analysis, 2023 & 2030 (USD Million)
- 5.3. Solid Phase Peptide Synthesis (SPPS)
- 5.3.1. Solid Phase Peptide Synthesis (SPPS) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.4. Liquid Phase Peptide Synthesis (LPPS)
- 5.4.1. Liquid Phase Peptide Synthesis (LPPS) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.5. Hybrid Technology
- 5.5.1. Hybrid Technology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Peptide Synthesis Market: Application Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Peptide Synthesis Market: Application Movement Analysis, 2023 & 2030 (USD Million)
- 6.3. Therapeutics
- 6.3.1. Therapeutics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.2. Cancer
- 6.3.2.1. Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.3. Metabolic
- 6.3.3.1. Metabolic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.4. Cardiovascular Disorder
- 6.3.4.1. Cardiovascular Disorder Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.5. Respiratory
- 6.3.5.1. Respiratory Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.6. GIT (Gastrointestinal Disorders)
- 6.3.6.1. GIT (Gastrointestinal Disorders) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.7. Infectious Diseases
- 6.3.7.1. Infectious Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.8. Pain
- 6.3.8.1. Pain Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.9. Dermatology
- 6.3.9.1. Dermatology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.10. CNS
- 6.3.10.1. CNS Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.11. Renal
- 6.3.11.1. Renal Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.12. Others
- 6.3.12.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4. Diagnosis
- 6.4.1. Diagnosis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.5. Research
- 6.5.1. Research Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Peptide Synthesis Market: End Use Estimates & Trend Analysis
- 7.1. Segment Dashboard
- 7.2. Peptide Synthesis Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
- 7.3. Pharmaceutical & Biotechnology Companies
- 7.3.1. Pharmaceutical & Biotechnology Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4. Contract Development & Manufacturing Organization/Contract Research Organization
- 7.4.1. Contract Development & Manufacturing Organization/Contract Research Organization Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5. Academic & Research Institutes
- 7.5.1. Academic & Research Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Peptide Synthesis Market: Regional Estimates & Trend Analysis
- 8.1. Peptide Synthesis Market Share, By Region, 2023 & 2030, USD Million
- 8.2. North America
- 8.2.1. North America Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.2.2. U.S.
- 8.2.2.1. U.S. Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.2.3. Canada
- 8.2.3.1. Canada Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.2.4. Mexico
- 8.2.4.1. Mexico Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3. Europe
- 8.3.1. Europe Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.2. UK
- 8.3.2.1. UK Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.3. Germany
- 8.3.3.1. Germany Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.4. France
- 8.3.4.1. France Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.5. Italy
- 8.3.5.1. Italy Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.6. Spain
- 8.3.6.1. Spain Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.7. Denmark
- 8.3.7.1. Denmark Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.8. Sweden
- 8.3.8.1. Sweden Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.9. Norway
- 8.3.9.1. Norway Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4. Asia Pacific
- 8.4.1. Asia Pacific Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.2. China
- 8.4.2.1. China Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.3. Japan
- 8.4.3.1. Japan Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.4. India
- 8.4.4.1. India Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.5. South Korea
- 8.4.5.1. South Korea Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.6. Australia
- 8.4.6.1. Australia Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.7. Thailand
- 8.4.7.1. Thailand Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5. Latin America
- 8.5.1. Latin America Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.2. Brazil
- 8.5.2.1. Brazil Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.3. Argentina
- 8.5.3.1. Argentina Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6. Middle East and Africa
- 8.6.1. Middle East and Africa Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.2. Saudi Arabia
- 8.6.2.1. Saudi Arabia Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.3. UAE
- 8.6.3.1. UAE Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.4. South Africa
- 8.6.4.1. South Africa Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.5. Kuwait
- 8.6.5.1. Kuwait Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 9. Competitive Landscape
- 9.1. Recent Developments & Impact Analysis by Key Market Participants
- 9.2. Company Categorization
- 9.3. Company Heat Map Analysis
- 9.4. Company Profiles
- 9.4.1. Thermo Fisher Scientific Inc.
- 9.4.1.1. Participant's Overview
- 9.4.1.2. Financial Performance
- 9.4.1.3. Product Benchmarking
- 9.4.1.4. Recent Developments/Strategic Initiatives
- 9.4.2. Merck KGaA
- 9.4.2.1. Participant's Overview
- 9.4.2.2. Financial Performance
- 9.4.2.3. Product Benchmarking
- 9.4.2.4. Recent Developments/Strategic Initiatives
- 9.4.3. GenScript
- 9.4.3.1. Participant's Overview
- 9.4.3.2. Financial Performance
- 9.4.3.3. Product Benchmarking
- 9.4.3.4. Recent Developments/Strategic Initiatives
- 9.4.4. Bachem Holding AG
- 9.4.4.1. Participant's Overview
- 9.4.4.2. Financial Performance
- 9.4.4.3. Product Benchmarking
- 9.4.4.4. Recent Developments/Strategic Initiatives
- 9.4.5. Biotage
- 9.4.5.1. Participant's Overview
- 9.4.5.2. Financial Performance
- 9.4.5.3. Product Benchmarking
- 9.4.5.4. Recent Developments/Strategic Initiatives
- 9.4.6. Creative Diagnostics
- 9.4.6.1. Participant's Overview
- 9.4.6.2. Financial Performance
- 9.4.6.3. Product Benchmarking
- 9.4.6.4. Recent Developments/Strategic Initiatives
- 9.4.7. PolyPeptide Group
- 9.4.7.1. Participant's Overview
- 9.4.7.2. Financial Performance
- 9.4.7.3. Product Benchmarking
- 9.4.7.4. Recent Developments/Strategic Initiatives
- 9.4.8. Syngene International Limited
- 9.4.8.1. Participant's Overview
- 9.4.8.2. Financial Performance
- 9.4.8.3. Product Benchmarking
- 9.4.8.4. Recent Developments/Strategic Initiatives
- 9.4.9. Puresynth Research Chemicals Pvt Ltd.
- 9.4.9.1. Participant's Overview
- 9.4.9.2. Financial Performance
- 9.4.9.3. Product Benchmarking
- 9.4.9.4. Recent Developments/Strategic Initiatives
- 9.4.10. Lonza
- 9.4.10.1. Participant's Overview
- 9.4.10.2. Financial Performance
- 9.4.10.3. Product Benchmarking
- 9.4.10.4. Recent Developments/Strategic Initiatives
- 9.4.1. Thermo Fisher Scientific Inc.
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.